由小细胞肺癌虹膜转移引起的新血管玻璃眼:一个病例呈现
A J Rallo-López1, J Orts-Llácer2, C Cauto-Picazo2
1Hospital Universitario y Politécnico La Fe, Valencia, Spain; Clínica Baviera-AIER EYE Group, Valencia, Spain.
Archivos de la Sociedad Espanola de Oftalmologia
|May 29, 2023
概括
小细胞肺癌可以扩散到眼睛,影响虹膜并导致玻璃眼. 放射治疗有效地治疗了由肺癌引起的虹膜转移病例,改善了患者的病情.
科学领域:
- 眼科医生 眼科 眼科
- 在瘤学瘤学.
背景情况:
- 小细胞肺癌 (SCLC) 可以转移到眼睛,直接或通过副瘤综合征.
- 虽然冠状腺转移很常见 (90%),但虹膜转移较少 (<10%).
相关概念视频
Glaucoma: Overview
636
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
636
Angle Closure Glaucoma: Treatment
584
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
584
Open Angle Glaucoma: Treatment
497
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
497


